A detailed history of Nwam LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Nwam LLC holds 2,773 shares of NVO stock, worth $242,277. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,773
Holding current value
$242,277
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $330,181 - $403,249
2,773 New
2,773 $330,000
Q1 2024

May 09, 2024

BUY
$102.11 - $135.92 $132,640 - $176,560
1,299 Added 51.3%
3,831 $491,000
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $1,316 - $1,581
-15 Reduced 0.59%
2,532 $261,000
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $231,624 - $508,228
2,547 New
2,547 $231,000
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $183,820 - $221,045
1,389 New
1,389 $221,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Nwam LLC Portfolio

Follow Nwam LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.